https://scibase.com/uk/ceo-letter-2/
CEO-LETTER 2 - SciBase
ceo letterscibase
https://scibase.com/us/comments-on-covid-19/
Comments on Covid-19 - SciBase
Sep 9, 2025 - The consequences of the Covid19 outbreak have started to affect SciBase from mid-March, and there is a high risk that these could lead to a significant...
commentscovidscibase
https://www.inderes.fi/en/releases/bulletin-from-the-extraordinary-general-meeting-in-scibase-holding-ab-publ-2
Bulletin from the extraordinary general meeting in SciBase Holding AB (publ) - Inderes
Today, an extraordinary general meeting has been held in SciBase Holding AB (publ) ("SciBase" or the "Company"). The general meeting resolved in accordance...
extraordinary general meetingfrom the
https://scibase.com/uk/scibase-publishes-the-annual-report-for-2019/
SciBase publishes the Annual report for 2019 - SciBase
Sep 9, 2025 - SciBase hereby announces that the Annual report for 2019 is available at the Company's website www.scibase.com.
the annual reportscibasepublishes
https://scibase.com/de/notice-to-extraordinary-general-meeting-in-scibase-holding-ab-publ/
Notice to extraordinary general meeting in Scibase Holding AB (publ) - SciBase
Sep 9, 2025 - Shareholders of SciBase Holding AB (publ), reg. no. 556773-4768 (the "Company"), are hereby summoned to an extraordinary general meeting to be held on 13 May...
extraordinary general meetingnoticescibaseholdingab
https://medtechspectrum.com/news/10/24342/scibase-surpasses-300000-patients-tested-with-nevisense-skin-cancer-detection-system.html
SciBase Surpasses 300,000 Patients Tested with Nevisense Skin Cancer Detection System
SciBase Surpasses 300,000 Patients Tested with Nevisense Skin Cancer Detection System
skin cancer detection